
USD
+$0.00
(+0.00%
)At Close (As of Oct 23, 2025)
$1.86B
Market Cap
-
P/E Ratio
-0.77
EPS
$43.11
52 Week High
$27.64
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $348M |
| Total Revenue | $465M |
| Cost Of Revenue | $118M |
| Costof Goods And Services Sold | $118M |
| Operating Income | -$40M |
| Selling General And Administrative | $291M |
| Research And Development | $96M |
| Operating Expenses | $388M |
| Investment Income Net | - |
| Net Interest Income | -$2M |
| Interest Income | $4.4M |
| Interest Expense | $6.4M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $19M |
| Income Before Tax | -$44M |
| Income Tax Expense | $1M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$45M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$37M |
| Ebitda | -$19M |
| Net Income | -$45M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $348M |
| Total Revenue | $465M |
| Cost Of Revenue | $118M |
| Costof Goods And Services Sold | $118M |
| Operating Income | -$40M |
| Selling General And Administrative | $291M |
| Research And Development | $96M |
| Operating Expenses | $388M |
| Investment Income Net | - |
| Net Interest Income | -$2M |
| Interest Income | $4.4M |
| Interest Expense | $6.4M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $19M |
| Income Before Tax | -$44M |
| Income Tax Expense | $1M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$45M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$37M |
| Ebitda | -$19M |
| Net Income | -$45M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
AtriCure, Inc. is a prominent medical device company headquartered in Mason, Ohio, focusing on pioneering technologies for surgical ablation in the treatment of cardiac arrhythmias, particularly atrial fibrillation. The company's innovative product portfolio is utilized across a broad spectrum of healthcare facilities in the U.S. and international markets, including Europe and Asia. Committed to advancing cardiac care, AtriCure emphasizes the integration of advanced technology and rigorous clinical research to improve patient outcomes and drive the adoption of minimally invasive surgical techniques. As a leader in its field, AtriCure is well-positioned to address the evolving needs of the cardiac care market.